Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Nonalcoholic Fatty Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03281083
What this trial is testing

Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Duke-NUS Graduate Medical School 29
Not applicableStudy completedNCT04336800
What this trial is testing

Multi-Parametric MRI Assessment of the Liver in Diabetic Volunteers (Partners Registry)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Perspectum 74
Testing effectiveness (Phase 2)Active Not RecruitingNCT06151964
What this trial is testing

A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight

Who this might be right for
Overweight and Obesity
AstraZeneca 166
Large-scale testing (Phase 3)Study completedNCT06117137
What this trial is testing

The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus

Who this might be right for
Fatty Liver, Nonalcoholic
Sohag University 150
Not applicableStudy completedNCT00536250
What this trial is testing

Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth

Who this might be right for
Impaired Glucose TolerancePre-diabetesChildhood Obesity+2 more
Yale University 255
Not applicableUnknownNCT06144593
What this trial is testing

The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Overweight and ObesityNon-Alcoholic Fatty Liver Disease+1 more
Hvidovre University Hospital 14
Not applicableStudy completedNCT03864510
What this trial is testing

NAFLD in Diabetes Type 2 in Primary Care

Who this might be right for
NAFLD
Linkoeping University 317
Post-approval studies (Phase 4)UnknownNCT01720719
What this trial is testing

Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty LiverDyslipidemiasDiabetes Mellitus
Xin Gao 120
Not applicableStudy completedNCT04820556
What this trial is testing

Gut Microbiota in Chronic Noncommunicable Diseases

Who this might be right for
Arterial HypertensionAtherosclerosis Occlusive DiseaseHeart Failure With Preserved Ejection Fraction+5 more
National Medical Research Center for Therapy and Preventive Medicine 1,084
Not applicableUnknownNCT03073343
What this trial is testing

A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon Insulin Dependent DiabetesALT
Southern California Institute for Research and Education 48
Post-approval studies (Phase 4)UnknownNCT06218342
What this trial is testing

Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Disease

Who this might be right for
Type 2 DiabetesNon-Alcoholic Fatty Liver Disease
Sir Run Run Shaw Hospital 156
Large-scale testing (Phase 3)Ended earlyNCT00577148
What this trial is testing

An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes

Who this might be right for
Fatty Liver
Sanofi 89
Not applicableLooking for participantsNCT06115876
What this trial is testing

Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program

Who this might be right for
Diabetes Mellitus Type 2, Diabetes Mellitus Type 1NAFLD - Nonalcoholic Fatty Liver DiseasePreDiabetes
Dasman Diabetes Institute 2,000
Post-approval studies (Phase 4)Study completedNCT07363707
What this trial is testing

A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes.

Who this might be right for
NAFLD (Nonalcoholic Fatty Liver Disease)
Beni-Suef University 108
Testing effectiveness (Phase 2)Study completedNCT05232071
What this trial is testing

Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus

Who this might be right for
NASH - Nonalcoholic SteatohepatitisDiabetes Mellitus, Type 2
Inventiva Pharma 39
Not applicableUnknownNCT03968354
What this trial is testing

NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand (RANKL)

Who this might be right for
Diabetes type2NASH - Nonalcoholic SteatohepatitisNAFLD
Assistance Publique - Hôpitaux de Paris 50
Testing effectiveness (Phase 2)Study completedNCT01975935
What this trial is testing

Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus Type 2Non-alcoholic Fatty Liver DiseaseObesity
University of Michigan 42
Not applicableStudy completedNCT05044130
What this trial is testing

Postprandial VLDL-triglyceride Metabolism in Type 2 Diabetes Patients With and Without NAFLD

Who this might be right for
NAFLDType 2 Diabetes
University of Aarhus 17
Not applicableLooking for participantsNCT06649162
What this trial is testing

Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy

Who this might be right for
Type 2 Diabetes
Boryung Pharmaceutical Co., Ltd 10,000
Not applicableActive Not RecruitingNCT07172997
What this trial is testing

Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers

Who this might be right for
MASLDT2DM (Type 2 Diabetes Mellitus)Non-alcoholic Fatty Liver Disease (NAFLD)+1 more
Royal College of Surgeons in Ireland - Medical University of Bahrain 163
Next Page